Shares of KP Tissue Inc. (TSE:KPT - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$8.46 and traded as high as C$8.50. KP Tissue shares last traded at C$8.45, with a volume of 23,348 shares.
Separately, TD Securities boosted their price target on KP Tissue from C$8.50 to C$9.00 and gave the company a "hold" rating in a report on Wednesday, August 14th.
Read Our Latest Stock Report on KPT
The stock's 50-day moving average price is C$8.48 and its 200 day moving average price is C$8.46. The firm has a market cap of C$84.25 million, a P/E ratio of 14.08, a price-to-earnings-growth ratio of -0.88 and a beta of 0.37.
KP Tissue (TSE:KPT - Get Free Report) last issued its quarterly earnings results on Tuesday, August 13th. The company reported C$0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.22 by C($0.10). The business had revenue of C$509.80 million for the quarter, compared to analysts' expectations of C$487.50 million. As a group, analysts forecast that KP Tissue Inc. will post 0.4400207 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 15th will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $0.72 annualized dividend and a yield of 8.52%. KP Tissue's dividend payout ratio (DPR) is presently 120.00%.
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.